# Core D: Clinical Research Core

> **NIH NIH P30** · EMORY UNIVERSITY · 2020 · $955,583

## Abstract

Project Summary: Clinical Research Core (Core D)
 The Clinical Research Core (Core D) will provide services that support researchers who are conducting
human subject research studies investigating the pathogenesis of HIV disease, treatment and prevention of
HIV, strategies to eliminate HIV from those who are infected, and the reduction of the long term morbidity
among those with HIV infection. Many aspects of the HIV epidemic in Georgia mirror those in resource-limited
settings around the world. Characterized by high rates of new HIV-infections, late treatment initiation, and
inconsistent connection with ongoing medical care; people living with HIV in Georgia are mostly poor, and
often present with AIDS-defining illnesses that are now less common in other parts of the country. In this
context, the Clinical Core will enable the conduct of scientifically rigorous HIV clinical and translational
research through the provision of state-of-the-art research infrastructure including shared research space,
laboratory services, and expert consultation in clinical research methods and study implementation. To support
investigators engaged in these activities the Core, in concert with the Biostatistics and Bioinformatics Core, will
expand the use of a sophisticated clinical database, the “HIV Disease Registry” that contains >13,000 unique
patients cared for at Emory-associated facilities, with >400,000 patient encounters representing over 60,000
person years of clinically relevant data. The Core will also provide access to a diverse array of biological
specimens and data from populations that are traditionally under-represented in HIV research, including
minority women, adolescents, pregnant women, and minority men who have sex with men. The Core's
specimen repository also allows investigators access to specimens and data from populations that are critical
to answering high priority research questions. These include elite controllers, long-term non-progressors,
people with acute HIV infection and/or acute HCV coinfection, and high-risk sero-negative men and women.
Finally, as part of its commitment to mentoring the next generation of investigators, the Core will continue its
successful program to foster career development of junior faculty and scientists who are new to HIV
translational research.
 The Core will have achieved our aims in the next grant cycle if our CFAR researchers have improved
methods to enhance earlier diagnosis and treatment, improve the continuum of care, reduce organ damage
associated with HIV and its treatment, develop new strategies towards a cure for HIV, and trained highly
productive young researchers.

## Key facts

- **NIH application ID:** 9989044
- **Project number:** 5P30AI050409-22
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Ighovwerha Ofotokun
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $955,583
- **Award type:** 5
- **Project period:** 2002-09-30 → 2022-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9989044

## Citation

> US National Institutes of Health, RePORTER application 9989044, Core D: Clinical Research Core (5P30AI050409-22). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9989044. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*